The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation

We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. Retrospective analysis of their medical records revealed that a mean ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Conchon, Monika, Sanabani, Sabri S., Bendit, Israel, Dinardo, Carla Luana, Dias, Lucia, Chamone, Dalton de Alencar Fischer, Dorlhiac-Llacer, Pedro Enrique, Dulley, Frederico Luiz
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://www.ncbi.nlm.nih.gov/pubmed/20107580
http://dx.doi.org/10.1155/2009/357093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809434/
https://www.ncbi.nlm.nih.gov/pubmed/20107580
http://dx.doi.org/10.1155/2009/357093

Ejemplares similares